Advertisement

FDA Panel Mulls Merck COVID-19 Antiviral Pill

0

Expert panel will vote later Tuesday on whether to recommend authorizing the drug for high-risk patients

Old Spice, Secret Antiperspirants Recalled Due to Benzene

0

Proctor & Gamble said that it has not received any reports of harm from the recalled products

Hospitals Lag in Sexual Harassment Policies

0

Findings reveal few of the top U.S. medical centers have policies addressing harassment of physicians and staff by patients

FDA Approves Imaging Drug That Can Help Surgeons Spot Ovarian Cancers

0

Drug is designed to improve surgeon's ability to detect ovarian cancer while operating on a patient

Cervical Cancer Deaths Down Following HPV Vaccine Introduction

0

Reductions in cervical cancer incidence, mortality in the U.S. greater for those aged 15 to 24 years than those aged 25 to 29, 30 to 39 years

Conventional IVF Noninferior to PGT-A for Live-Birth Rate

0

Cumulative live-birth rate with use of conventional IVF noninferior to that for embryo selection with preimplantation genetic testing for aneuploidy

Merck’s COVID-19 Pill Appears Effective, but May Pose Pregnancy Risks: FDA

0

Given safety concerns, FDA scientists said Merck has agreed the drug will not be used in children.

RSNA: CT Imaging for Cancer Down During COVID-19 Peak in 2020

0

In post-COVID-19 peak period in 2020, CT volume still down for cancer screening and initial workup with inconsistent recovery for active cancer

Low-to-Moderate Caffeine Intake Not Tied to Maternal Health Risk

0

Limited caffeine intake, within recommended amounts, during the second trimester associated with lower risk for gestational diabetes

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...